| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A constructive critique of the draft ICH E9 Addendum
|
Scharfstein, Daniel O
|
|
2019
|
16 |
4 |
p. 375-380
|
artikel
|
| 2 |
Addressing guideline and policy changes during pragmatic clinical trials
|
Curtis, Lesley H
|
|
2019
|
16 |
4 |
p. 431-437
|
artikel
|
| 3 |
Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health
|
Ma, Qinli
|
|
2019
|
16 |
4 |
p. 419-430
|
artikel
|
| 4 |
Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials
|
Molinari, Nicolas
|
|
2019
|
16 |
4 |
p. 440-442
|
artikel
|
| 5 |
A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis
|
Mehrotra, Devan V
|
|
2019
|
16 |
4 |
p. 339-344
|
artikel
|
| 6 |
Collaborative implementation of a community-based exercise intervention with a partnering rural American Indian community
|
Chadwick, Jennifer Q
|
|
2019
|
16 |
4 |
p. 391-398
|
artikel
|
| 7 |
Commentary on Curtis et al.
|
Cook, Andrew
|
|
2019
|
16 |
4 |
p. 438-439
|
artikel
|
| 8 |
Defining treatment effects: A regulatory perspective
|
Permutt, Thomas
|
|
2019
|
16 |
4 |
p. 345-349
|
artikel
|
| 9 |
Proceedings of the University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis
|
Ellenberg, Susan S
|
|
2019
|
16 |
4 |
p. 337-338
|
artikel
|
| 10 |
Quantifying time-varying cause-specific hazard and subdistribution hazard ratios with competing risks data
|
Diao, Guoqing
|
|
2019
|
16 |
4 |
p. 363-374
|
artikel
|
| 11 |
The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration
|
Klopstock, Thomas
|
|
2019
|
16 |
4 |
p. 410-418
|
artikel
|
| 12 |
The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: Rationale, design and methodologies
|
Putt, Mary E
|
|
2019
|
16 |
4 |
p. 399-409
|
artikel
|
| 13 |
University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (afternoon panel session)
|
Little, Roderick J
|
|
2019
|
16 |
4 |
p. 381-390
|
artikel
|
| 14 |
University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (morning panel session)
|
Rockhold, Frank W
|
|
2019
|
16 |
4 |
p. 350-362
|
artikel
|
Tijdschrift beschrijving